Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUMO2 pseudogene 1 is a non-protein coding pseudogene related to the SUMO2 gene, which encodes a small ubiquitin-like modifier protein involved in critical cellular processes such as nuclear transport, transcriptional regulation, DNA repair, mitosis, and signal transduction[3][4][5]. As a pseudogene, SUMO2P1 does not produce a functional protein and generally lacks direct biological function, disease association, or utility as a therapeutic target[5]. While the coding gene SUMO2 is essential for many cellular pathways, its pseudogenes, including SUMO2P1, are typically not functional and are not valid drug targets; they may exist as relics of gene duplication or evolutionary processes and may sometimes serve regulatory or genomic roles, but there is no current evidence for a specific function or clinical utility for SUMO2 pseudogene 1[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUMO2 pseudogene 1 (SUMO2P1).